| Anthropometrics at birth and risk of a primary central nervous system tumour: a systematic review and meta-analysis MK Georgakis, EI Kalogirou, A Liaskas, MA Karalexi, P Papathoma, ... European journal of cancer 75, 117-131, 2017 | 42 | 2017 |
| Consumption of fruits, vegetables, and risk of hematological malignancies: a systematic review and meta-analysis of prospective studies TN Sergentanis, T Psaltopoulou, I Ntanasis-Stathopoulos, A Liaskas, ... Leukemia & Lymphoma 59 (2), 434-447, 2018 | 34 | 2018 |
| Monoclonal antibodies in the treatment of diffuse Large b-cell lymphoma: Moving beyond rituximab SG Papageorgiou, TP Thomopoulos, A Liaskas, TP Vassilakopoulos Cancers 14 (8), 1917, 2022 | 22 | 2022 |
| Prognostic factors and survival of gliomatosis cerebri: a systematic review and meta-analysis MK Georgakis, G Tsivgoulis, D Spinos, A Liaskas, U Herrlinger, ... World neurosurgery 120, e818-e854, 2018 | 18 | 2018 |
| Incorporating monoclonal antibodies into the first-line treatment of classical Hodgkin lymphoma TP Vassilakopoulos, A Liaskas, P Pereyra, P Panayiotidis, ... International Journal of Molecular Sciences 24 (17), 13187, 2023 | 12 | 2023 |
| Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors TP Vassilakopoulos, E Kravvariti, F Panitsas, MK Angelopoulou, ... Blood Cancer Journal 12 (7), 102, 2022 | 11 | 2022 |
| PF297 COMPARISON OF RITUXIMAB DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) WITH RITUXIMAB‐CHOP (R‐CHOP) CHEMOTHERAPY IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) T Vassilakopoulos, Z Mellios, E Verigou, S Papageorgiou, ... HemaSphere 3, 100-101, 2019 | 4 | 2019 |
| H10: Long-term results could be misleading without an updated reading key for positron emission tomography TP Vassilakopoulos, A Liaskas, P Pereyra, A Gallamini Journal of clinical oncology: official journal of the American Society of …, 2024 | 3 | 2024 |
| Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients TP Vassilakopoulos, M Arapaki, PT Diamantopoulos, A Liaskas, ... Cancers 16 (2), 238, 2024 | 3 | 2024 |
| Pleural fluid overload-associated large B-cell lymphoma with a formerly double-hit genotype A Liaskas, V Xanthopoulos, M Arapaki, TP Vassilakopoulos The Lancet Haematology 10 (4), e306, 2023 | 2 | 2023 |
| Are we identifying malnutrition in hospitalized patients with hematologic malignancies? Results from a quality clinical audit E Kanioura, IG Tzanninis, KA Poulia, A Stamou, A Liaskas, D Politis, ... Diseases 10 (3), 40, 2022 | 2 | 2022 |
| P114: Very late relapses in patients with Hodgkin Lymphoma occuring≥ 5 years after initial treament with chemotherapy±radiotherapy: Treatment strategies and prognostic factors … TP Vassilakopoulos, A Liaskas, G Rizzuto, A Symeonidis, M Palma, ... HemaSphere 6, 53, 2022 | 1 | 2022 |
| P1229: Rituximab-dose-adjusted epoch (r-da-epoch) in primary mediastinal large B-cell lymphoma (PMLBCL): real-life experience on 225 patients from 4 countries T Vassilakopoulos, B Ferhanoglu, NA Horowitz, J Apostolidis, Z Mellios, ... HemaSphere 6, 1114-1115, 2022 | 1 | 2022 |
| P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): THE … T Vassilakopoulos, A Piperidou, Z Mellios, E Verigou, C Kalpadakis, ... HemaSphere 6, 1115-1116, 2022 | 1 | 2022 |
| Very Late Relapses in Hodgkin Lymphoma: A Critical Comparison of Major Published Studies A Liaskas, F Panitsas, E Kravvariti, MK Angelopoulou, GA Pangalis, ... Haema 13, 14-19, 2022 | 1 | 2022 |
| Very early onset of therapy-related acute myeloid leukemia with 11q23 rearrangement presenting with unusual PET findings after R-DA-EPOCH for primary mediastinal large B-cell … C Chatzidimitriou, P Rondogianni, M Arapaki, A Liaskas, E Plata, ... Medicina 58 (1), 48, 2021 | 1 | 2021 |
| Disease Bulk and/or Very High LDH As Adverse Factors in IPI 1-2 Diffuse Large B-Cell Lymphoma (DLBCL): A Hellenic Database Validation of the LEO Cohort TP Vassilakopoulos, MP Arapaki, C Apostolopoulou, E Verrou, ... Blood 144, 6362, 2024 | | 2024 |
| Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Steroids (PolaRCHP) in Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Real-Life Experience in Greece TP Vassilakopoulos, MP Arapaki, C Apostolopoulou, G Kaiafa, A Mpanti, ... Blood 144, 7767, 2024 | | 2024 |
| The Prognostic Significance of Serum β2-Microglobulin Levels (sβ2m) in Diffuse Large B-Cell Lymphoma (DLBCL) MP Arapaki, E Verrou, SG Papageorgiou, A Anastasopoulou, S Sachanas, ... Blood 144 (Supplement 1), 6476-6476, 2024 | | 2024 |
| Hematology-Cell Morphology--Case 24. JV Asimakopoulos, L Papageorgiou, J Drandakis, I Vasilopoulos, ... Archives of Hellenic Medicine/Arheia Ellenikes Iatrikes 41 (3), 2024 | | 2024 |
